Acquisition Announced

Zimmer Biomet acquisition of Alafair Biosciences

US$375m consideration

Announced Aug 2026 (approx.)

Advisers

Alafair Biosciences

Target

Financial adviser

Zimmer Biomet

Acquirer

Not disclosed

Target
Alafair Biosciences
Acquirer
Zimmer Biomet
Target based in
United States
Buyer based in
United States
Sector
Medtech

In the league tables

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.